CD34 and disease arising from reactivation of latent virus: Recently, it has been shown that CD34+ progenitor cells (that include HSCs and MPPs) are susceptible to latent infection ex vivo, and that integrated provirus was detected among CD34+ cells from HAART-treated patients (Carter et al., 2010).